Avoiding an FDA 483 at a Pre-Approval Inspection for NDA & ANDA

By Christina Sanchez Miller, MPH

  03/08/2019

  Category: Good Industry Practices

Every US FDA ANDA or NDA application requires time and money to develop drugs that will enter the U.S. market. Imagine spending...

Read More